Gabapentin enakarbil
Из Википедије, слободне енциклопедије
 |
|
| Klinički podaci | |
|---|---|
| AHFS/Drugs.com | enacarbil.html Monografija |
| Identifikatori | |
| CAS broj | 478296-72-9 |
| ATC kod | nije dodeljen |
| PubChem[1][2] | 9883933 |
| DrugBank | DB08872 |
| ChemSpider[3] | 8059607 |
| ChEBI | CHEBI:68840  |
| Hemijski podaci | |
| Formula | C16H27NO6 |
| Mol. masa | 329.389 |
| SMILES | eMolekuli & PubHem |
|
|
| Farmakokinetički podaci | |
| Poluvreme eliminacije | 5,1 - 6,0 h |
| Izlučivanje | Renalno (94%) |
| Farmakoinformacioni podaci | |
| Trudnoća | ? |
| Pravni status | |
| Način primene | Oralno |
Gabapentin enakarbil (Horizant) prolek je gabapentina. On se koristi za lečenje sindroma nemirnih nogu (RLS) i posterpetske neuralgije (PHN) kod odraslih osoba.[4][5][6]
Osobine[уреди]
| Osobina | Vrednost |
|---|---|
| Broj akceptora vodonika | 7 |
| Broj donora vodonika | 2 |
| Broj rotacionih veza | 9 |
| Particioni koeficijent[7] (ALogP) | 3,5 |
| Rastvorljivost[8] (logS, log(mol/L)) | -3,9 |
| Polarna površina[9] (PSA, Å2) | 105,4 |
Reference[уреди]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.“. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities“. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining“. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.
- ↑ Cundy KC, Annamalai T, Bu L, De Vera J, Estrela J, Luo W, Shirsat P, Torneros A, Yao F, Zou J, Barrett RW, Gallop MA: XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys. J Pharmacol Exp Ther. 2004 Oct;311(1):324-33. Epub 2004 May 14. PMID 15146029
- ↑ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs“. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682.
- ↑ Nucleic Acids Res (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets“. Nucleic acids research 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412.
- ↑ Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods“. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o.
- ↑ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices“. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.
- ↑ Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties“. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.
Literatura[уреди]
- Hardman JG, Limbird LE, Gilman AG. (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10 ed.). New York: McGraw-Hill. DOI:10.1036/0071422803. ISBN 0071354697.
- Thomas L. Lemke, David A. Williams, ed. (2007). Foye's Principles of Medicinal Chemistry (6 ed.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.
